Clinical Trial Update: A Study to Assess the Survival of Non-small Cell Lung Cancer Patients Treated With Tarceva After Failed Chemotherapy Treatment

View source ↗

Summary

Clinical trial update on Tarceva (erlotinib) in non-small cell lung cancer patients after failed chemotherapy; the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Squamous Non-Small Cell Lung Cancer | Status: TERMINATED | Results posted: 2016-07-28